share_log

8-K: Current report

SEC ·  Apr 17 04:42
Summary by Futu AI
Adial Pharmaceuticals, Inc., a Delaware-incorporated company listed on the Nasdaq Capital Market under the trading symbol ADIL, has filed a Form 8-K with the United States Securities and Exchange Commission on April 10, 2024. The report announces the termination of the consulting agreement with Dr. Bankole A. Johnson, who has served as the company's Chief Medical Officer. The agreement, which began on March 24, 2019, and was amended on March 22, 2022, and September 8, 2022, will be effectively terminated on May 17, 2024. Following this date, Dr. Johnson will no longer hold the position of Chief Medical Officer at Adial Pharmaceuticals. The company has fulfilled the SEC's requirements by having the report signed by President and Chief Executive Officer Cary J. Claiborne.
Adial Pharmaceuticals, Inc., a Delaware-incorporated company listed on the Nasdaq Capital Market under the trading symbol ADIL, has filed a Form 8-K with the United States Securities and Exchange Commission on April 10, 2024. The report announces the termination of the consulting agreement with Dr. Bankole A. Johnson, who has served as the company's Chief Medical Officer. The agreement, which began on March 24, 2019, and was amended on March 22, 2022, and September 8, 2022, will be effectively terminated on May 17, 2024. Following this date, Dr. Johnson will no longer hold the position of Chief Medical Officer at Adial Pharmaceuticals. The company has fulfilled the SEC's requirements by having the report signed by President and Chief Executive Officer Cary J. Claiborne.
Helpful
Not Helpful

This announcement is a separate document:

Doc 1

The information provided by Futu AI is automatically generated by third-party artificial intelligence (AI) software based on news content. It is only available to users located outside of China mainland.


The above content is for informational or educational purposes only and does not constitute any investment advice related to Futu. Although we strive to ensure the truthfulness, accuracy, and originality of all such content, we cannot guarantee it.